Snap-8

Product Overview: SNAP-8 (Acetyl Octapeptide-3)

SNAP-8 (Acetyl Octapeptide-3) is an elongated synthetic octapeptide derived from the N-terminal end of the protein SNAP-25. Designed as an advanced evolution of the hexapeptide Argireline (Acetyl Hexapeptide-8), SNAP-8 mimics SNAP-25 and competes with it for a position in the SNARE (Soluble N-ethylmaleimide-sensitive factor Attachment Protein Receptor) complex. By destabilizing this complex, SNAP-8 inhibits the calcium-dependent exocytosis of neurotransmitters (specifically acetylcholine) at the neuromuscular junction, serving as a primary model for non-invasive neuromuscular attenuation and anti-wrinkle mechanism studies.

Primary Research Applications & Reasons for Study

• SNARE Complex Competitive Inhibition: Outcompeting natural SNAP-25 to destabilize the SNARE core complex, preventing vesicle fusion with the presynaptic membrane.
• Neurotransmitter Exocytosis Blockade: Suppressing calcium-dependent acetylcholine release across neuronal junctions in muscle and dermal tissue assays.
• Dermal Expression Lines & Smoothness: Investigating the reduction of micro-contractions that drive expression lines and dynamic mechanical creasing in tissue models.
• Comparative Efficacy Assays: Evaluating potency, binding affinity, and stability kinetics against shorter ancestral sequences such as Argireline.

Expected Research Results & Timeline Metrics

• Phase 1 / Hours 1–48
  Immediate Presynaptic Inhibition: Rapid uptake into neuronal culture, competitive displacement of native SNAP-25, and measurable reduction of acetylcholine signaling.
• Phase 2 / Weeks 1–2
  Attenuated Contraction & Surface Smoothing: Statistically significant reduction in micro-contraction frequency and initial reduction of depth in surface topographic line models.
• Phase 3 / Weeks 3–6
  Matrix Relaxation & Wrinkle Depth Reduction: Up to ~35–63% reduction in expression line depth and roughness markers across reconstituted skin and 3D epidermal substrate assays.

Key Research Benefits

• Enhanced Potency Over Argireline: Extended octapeptide chain provides higher affinity binding and superior inhibition of SNARE complex assembly compared to hexapeptides.
• Non-Paralytic Mechanism: Smooths dynamic lines by attenuating signal intensity without permanently paralyzing nerve terminals or destroying SNAP-25 proteins.
• High Topical & In Vitro Stability: Acetylated N-terminus offers superior peptide stability against enzymatic cleavage in cell culture media.
• Topical Neuromuscular Standard: Essential reference compound for investigating non-invasive cosmetic science and topical botulinum toxin alternatives.